Tirzepatide Pens: What They Are and How to Use Them

Picture the morning you open your first pen

It arrives in plain, unbranded packaging. Inside is the Mounjaro KwikPen, a slim, pre-filled auto-injector about the length of a marker pen. There is no separate vial to draw up, no needle to attach by hand. You click the cap off, press the pen against clean skin (abdomen, thigh or upper arm all work), and press the button. A click confirms the dose has been delivered. The whole process takes under a minute once you are comfortable with it.

That simplicity is intentional. Eli Lilly designed the KwikPen so that people with no prior injection experience can use it at home without support. A detailed walkthrough of each step (including what to do if the window does not turn, or if you see a bubble) is set out in our guide to using the tirzepatide pen. The injection technique page covers pinching the skin, angle, and what the brief sting actually feels like for most people.

One practical note: the pen needs to come out of the fridge around 30 minutes before you use it. A cold injection is not dangerous, but it can be more uncomfortable. Lots of people keep their current pen in the fridge door and set a reminder while the kettle boils, small habit, noticeably easier experience.

Which tirzepatide pen strength is which, and why that matters

Tirzepatide pens are available in six UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Treatment always starts at 2.5 mg. That starting strength exists to let your body adjust to the medicine (particularly the gastrointestinal effects) rather than to produce weight loss straight away. From there, a prescriber titrates the dose upward, typically in four-week steps, based on how you are tolerating the current pen and how your weight is responding.

The 2.5 mg pen is physically identical to every other strength in the range; the difference is purely in the concentration of tirzepatide inside the cartridge. This matters because some sellers online advertise individual pens at a specific strength and price without making clear that those pens are prescription-only and that taking the wrong strength (or jumping doses without clinical oversight) carries real risks. Each individual tirzepatide pen in a legitimate supply has a batch number, an expiry date and a package insert; if any of those are absent, the pen's origin is uncertain.

The MHRA has seized large quantities of counterfeit weight-loss pens in recent years, including fake tirzepatide devices manufactured illegally in the UK. Verified supply through a GPhC-registered pharmacy is the only way to be confident that what is inside the pen matches what is on the label. That register is publicly searchable; nume's registration number is 9012878.

Side effects linked specifically to the injection and the pen device

Most side effects with tirzepatide are gastrointestinal: nausea, loose stools, constipation, indigestion, reflux. These are effects of the medicine itself, not the pen format, and they tend to be most noticeable after starting or after a dose increase, often easing within the first week or two. The tirzepatide injection side effects page goes into each of these in more detail, including practical ways to manage nausea during the adjustment period.

The injection site itself can cause redness, mild swelling or itching, common with any subcutaneous injection. Rotating between the abdomen, thigh and upper arm each week significantly reduces this. Alcohol swabs before injecting are a simple step that reduces the risk of local infection.

There are rarer side effects that warrant prompt medical attention. In January 2026, the MHRA issued a Drug Safety Update noting that acute pancreatitis is a known but infrequent risk with GLP-1 medicines: severe, persistent stomach pain (especially pain that spreads toward the back) should prompt a same-day call to NHS 111 or your GP, not a wait-and-see approach. Gallbladder problems and signs of serious allergic reaction (swelling of the face or throat, difficulty breathing) are also in that category. Any suspected side effect can be reported directly at the MHRA Yellow Card scheme.

Storage, disposal, and the clinical assessment that comes first

Unused tirzepatide pens belong in the fridge, kept between 2°C and 8°C, away from the freezer compartment. Freezing damages the medicine. The leaflet inside each pack specifies the exact room-temperature window once a pen has been removed from the fridge; it is not indefinite, and it differs from batch to batch, so the leaflet (not an online estimate) is the right reference. If you are travelling, see our dedicated tirzepatide storage and fridge guide for advice on keeping pens safe away from home.

Used pens must go into a sharps container, never into a household bin or recycling. A 1-litre sharps container is the right size for home use; your local council or pharmacy will advise on collection. This is not optional, a loose used pen is a needle-stick risk to whoever handles the bin.

The bigger point underlying all of this is that these pens sit within a clinical framework. Tirzepatide is a prescription-only medicine, which means a prescriber assesses your BMI, medical history, current medicines and weight-related conditions before any pen is issued. For context on what private tirzepatide treatment costs in the UK and what that figure typically covers, the pricing page sets out the current picture honestly. The full Mounjaro guide covers the clinical programme behind tirzepatide in more depth, including the trial evidence and the NICE recommendation. If you are ready to find out whether treatment is clinically right for you, a free consultation with one of our prescribers is the next step.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day it is submitted, a real clinician, not a decision algorithm. If approved, your pens are dispatched the same day (for orders placed before noon, Monday to Friday) and delivered free the next working day by DPD, in plain packaging. Start your free consultation to see whether tirzepatide is right for you.